IL-33, ST2, and ILC Pathways

26 ta ish

1. YURAK YETISHMOVCHILIGIDA BIOKIMYOVIY MARKERLAR

   Numonova Marjona, Axmadjonov Qudratillo

   MaqolaAtherosclerosis and Cardiovascular DiseasesZenodo (CERN European Organization for Nuclear Research)20260 iqtibos

   ABIABI:AkademIndex/openalex/2026.article.022868